• Bicycle Therapeutics Chief Operating Officer Jennifer Scott Perry reported selling 1,412 ordinary shares on July 2 and July 6.
• Sales were priced at USD 4.27 to USD 4.34 per share.
• Perry held 91,052 ordinary shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bicycle Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002119908-26-000007), on July 07, 2026, and is solely responsible for the information contained therein.